Advertisement

Topics

Merck to buy German biotech Rigontec for €115m

19:00 EDT 6 Sep 2017 | Pharmaceutical Technology

Merck is set to acquire German biotechnology firm Rigontec for an upfront cash payment of €115m.

Original Article: Merck to buy German biotech Rigontec for €115m

NEXT ARTICLE

More From BioPortfolio on "Merck to buy German biotech Rigontec for €115m"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...